Navigation Links
Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014
Date:7/31/2014

cured notes125,000125,000Capital lease obligations, less current portion6,0258,049Liability related to receipt of refundable milestone payment70,00070,000Liability related to sale of future royalties, less current portion121,431121,520Deferred revenue, less current portion88,91882,384Other long-term liabilities17,76819,256Total liabilities513,497524,430Commitments and contingenciesStockholders' equity (deficit) :Preferred stock--Common stock1211Capital in excess of par value1,776,7461,643,660Accumulated other comprehensive loss(887)(1,181)Accumulated deficit(1,811,231)(1,732,393)Total stockholders' equity (deficit) (35,360)(89,903)Total liabilities and stockholders' equity (deficit) $
478,137
$
434,527
(1) The consolidated balance sheet at December 31, 2013 has been derived from the audited financial statements at that date but does not include all of the information and notes required by generally accepted accounting principles in the United States for complete financial statements. NEKTAR THERAPEUTICSCONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS(I
'/>"/>
SOURCE Nektar Therapeutics
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. Nektar to Announce Financial Results for the Second Quarter 2014 on Thursday, July 31, 2014, After Close of U.S.-Based Financial Markets
2. Nektar Therapeutics President and CEO, Howard W. Robin, To Present at the 32nd Annual J.P. Morgan Healthcare Conference in San Francisco, CA
3. Nektar Therapeutics Reports Financial Results for the Third Quarter of 2013
4. Nektar to Announce Financial Results for the Third Quarter of 2013 on Thursday, November 7, 2013, After Close of U.S.-Based Financial Markets
5. Nektar Reports that Partner AstraZeneca Announced European Medicines Agency Acceptance of Marketing Authorisation Application for Naloxegol
6. Nektar Therapeutics Reports Financial Results for the Second Quarter of 2013
7. Nektar to Announce Financial Results for the Second Quarter of 2013 on Thursday, August 8, 2013, After Close of U.S.-Based Financial Markets
8. Nektar Completes Enrollment in Phase 3 BEACON Study of Etirinotecan Pegol in Women With Metastatic Breast Cancer
9. Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence
10. Nektar Presents Positive Preclinical Data for NKTR-214, a Novel Cancer Immunotherapy, At the 2013 American Society of Clinical Oncology Annual Meeting
11. Nektar Presents Target-Specific Biomarkers Being Assessed in Ongoing Phase 3 BEACON Study of Etirinotecan Pegol for the Treatment of Metastatic Breast Cancer at the 2013 American Society of Clinical Oncology Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)...  Cochlear Corporation Vice President of U.S. Sales ... join Valencia Technologies ( www.valenciatechnologies.com ) and his ... who is the CEO of Valencia.  Schloffman will ... be responsible for generating enthusiasm and support for ... coin-sized neuromodulation device in the treatment of resistant ...
(Date:3/30/2015)... --  MultiVir Inc. ("MultiVir"), a clinical-stage gene therapy ... the treatment of multiple oncological indications, today announced that ... S-1 with the U.S. Securities and Exchange Commission ("SEC") ... of its common stock. The number of shares to ... offering have not yet been determined. MultiVir has applied ...
(Date:3/30/2015)... 2015   GlassesUSA , the online retailer specializing ... in new financing led by Viola Private Equity , ... GlassesUSA,s aggressive business growth and accelerate their expansion as a ... both B2C and B2B. GlassesUSA was founded in ... Rothman , and CTO Roy Yamner . Leveraging their ...
Breaking Medicine Technology:Cochlear VP of U.S. Sales Jerry Schloffman Accepts Chief of Market Development Position at Valencia Technologies 2MultiVir Files Registration Statement for Proposed Initial Public Offering 2GlassesUSA.com Raises $12.5 Million Growth Round Led By Viola Private Equity 2GlassesUSA.com Raises $12.5 Million Growth Round Led By Viola Private Equity 3
... Mass., June 04, 2007 /PRNewswire-FirstCall/ -- Boston,Scientific ... article,in the Journal of of Cardiology (JACC) ... the Company's second-generation,TAXUS(R) Liberte(TM)(1) paclitaxel-eluting stent system. ... JACC concluded that the shorter,procedure time and ...
... Clinical Data on Thalidomide in Multiple Myeloma,Presented at ... CHICAGO, June 04, 2007 /PRNewswire-FirstCall/ -- Pharmion,Corporation today ... study,demonstrating that the addition of Thalidomide to standard ... patients aged 75,or older with newly diagnosed multiple ...
Cached Medicine Technology:Positive Results for Second-Generation Taxus Liberte Coronary Stent,System Highlighted in Journal of American College of Cardiology 2Positive Results for Second-Generation Taxus Liberte Coronary Stent,System Highlighted in Journal of American College of Cardiology 3Positive Results for Second-Generation Taxus Liberte Coronary Stent,System Highlighted in Journal of American College of Cardiology 4Adding Thalidomide to Standard Therapy Improves Survival in Newly,Diagnosed Multiple Myeloma Patients Over Age 75 2Adding Thalidomide to Standard Therapy Improves Survival in Newly,Diagnosed Multiple Myeloma Patients Over Age 75 3Adding Thalidomide to Standard Therapy Improves Survival in Newly,Diagnosed Multiple Myeloma Patients Over Age 75 4Adding Thalidomide to Standard Therapy Improves Survival in Newly,Diagnosed Multiple Myeloma Patients Over Age 75 5Adding Thalidomide to Standard Therapy Improves Survival in Newly,Diagnosed Multiple Myeloma Patients Over Age 75 6
(Date:3/30/2015)... 31, 2015 Wireless Analytics, LLC ... has been announced as one of the Boston Business ... fastest-growing private companies in Massachusetts. The list represents ... revenue growth from 2011 through 2014. 2015 marks ... Journal has recognized Wireless Analytics’s revenue growth. The ...
(Date:3/30/2015)... NY (PRWEB) March 31, 2015 ... Owner / Operator for Diamond Pharmacy Services, as ... Mitchell is recognized with this prestigious distinction for ... organization of professional women in the country, spanning ... of Professional Women is a powerfully vibrant networking ...
(Date:3/30/2015)... Dallas-Fort Worth, TX (PRWEB) March 31, 2015 ... has served as an advocate for the provision ... nationally-recognized standards and through its survey and accreditation ... process, education, and research, AAAHC aims to promote ... care organizations must undergo rigorous self-assessments and on-site ...
(Date:3/30/2015)... 2015 Hosted by the California ... free, two-day dental clinic in Sacramento provided $2 million ... , In addition to providing free dental services ... to care, CDA Cares educates the public and policymakers ... need for an adequately funded dental safety net, which ...
(Date:3/30/2015)... CA (PRWEB) March 30, 2015 KIND LED’s ... LED grow light products in 2015. The excellent value and ... them to take the pole position in the race for ... feature of the KIND LED suite of grow lights is ... most plant-friendly Photosynthetic Active Radiation (PAR) wavelengths that plants are ...
Breaking Medicine News(10 mins):Health News:Wireless Analytics Growth Streak Continues; Named to Boston Business Journal’s Pacesetters Second Year In a Row 2Health News:Wireless Analytics Growth Streak Continues; Named to Boston Business Journal’s Pacesetters Second Year In a Row 3Health News:National Association of Professional Women Announces Tamara Mitchell, Owner / Operator of Diamond Pharmacy Services, a 2015 Professional Woman of the Year 2Health News:Precinct Ambulatory Surgery Center Achieves Accreditation Association for Ambulatory Health Care Accreditation 2Health News:CDA Cares Sacramento Dental Clinic Provides $2 Million in Care 2Health News:Best LED Grow Lights of 2015 Are Being Led By KIND LED 2
... to repair nerve fiber damage , , TUESDAY, April 28 ... and stabilize damage done to the myelin sheath in people ... Idec and Elan Corp shows. , MS is nervous system ... by MS patients are caused by damage to the myelin ...
... 29 /PRNewswire-Asia-FirstCall/ -- Shengtai,Pharmaceutical, Inc. (OTC Bulletin ... manufacturer and distributor of high-quality, pharmaceutical grade,glucose ... hosted a conference at the,Company,s headquarters to ... as well as conducted,high-level discussions with key ...
... 29 , - Bausch ... Campaign , Bausch & Lomb ... in its continued effort to improve the habits of,contact ... the THINK,EYEGIENE(TM) campaign, Bausch & Lomb is introducing ReNu ...
... 2009 First Quarter Reported Diluted Earnings per Share were $0.89, ... per Share, , Excluding Certain Significant Items, Increased ... First Quarter and , Increased 2%, Excluding the ... the Impact of Foreign , Exchange, was Driven ...
... 2009 AT 13.00 CET -- Advances in ... diseases and make ever more accurate diagnoses. But ... (IAEA) say that overuse of high-tech scanning procedures may ... IAEA, in collaboration with other international organizations, is developing ...
... Bill to Advance Education and Informed Consent Recommendations Established ... Cord Blood Registry (CBR), the global ... cells from umbilical cord blood, announced its support of ... entitled the "Cord Blood Education and Awareness Act of ...
Cached Medicine News:Health News:Shengtai Pharmaceutical Hosts Key Customers at Its Headquarters for Facility Tour and Technology Exchange Conference 2Health News:Shengtai Pharmaceutical Hosts Key Customers at Its Headquarters for Facility Tour and Technology Exchange Conference 3Health News:A Clear Solution for Healthy Eyes 2Health News:A Clear Solution for Healthy Eyes 3Health News:A Clear Solution for Healthy Eyes 4Health News:Wyeth Reports Earnings Results for the 2009 First Quarter 2Health News:Wyeth Reports Earnings Results for the 2009 First Quarter 3Health News:Wyeth Reports Earnings Results for the 2009 First Quarter 4Health News:Wyeth Reports Earnings Results for the 2009 First Quarter 5Health News:Wyeth Reports Earnings Results for the 2009 First Quarter 6Health News:Wyeth Reports Earnings Results for the 2009 First Quarter 7Health News:Wyeth Reports Earnings Results for the 2009 First Quarter 8Health News:Wyeth Reports Earnings Results for the 2009 First Quarter 9Health News:Wyeth Reports Earnings Results for the 2009 First Quarter 10Health News:Wyeth Reports Earnings Results for the 2009 First Quarter 11Health News:Wyeth Reports Earnings Results for the 2009 First Quarter 12Health News:IAEA calls for enhanced radiation protection of patients 2Health News:IAEA calls for enhanced radiation protection of patients 3Health News:IAEA calls for enhanced radiation protection of patients 4Health News:IAEA calls for enhanced radiation protection of patients 5Health News:Cord Blood Registry Supports Introduction of the Cord Blood Education and Awareness Act of 2009 2Health News:Cord Blood Registry Supports Introduction of the Cord Blood Education and Awareness Act of 2009 3
... ergonomic chairs with concave seats and ... Select options like seats, backrests, armrests, ... chairs are recommended for the following ... static control, health care and office. ...
... chairs with concave seats and standard-sized ... options like seats, backrests, armrests, and ... are recommended for the following environments: ... control, health care and office. • ...
... Basic ergonomic chairs with concave ... support • Select options like seats, ... • BTC/1Q chairs are recommended for ... clean room, static control, health care ...
... Basic ergonomic chairs with concave seats ... • Select options like seats, backrests, ... BTC/1Q chairs are recommended for the ... room, static control, health care and ...
Medicine Products: